A phase II study of concurrent chemoradiotherapy combined with a weekly paclitaxel and 5-fluorouracil regimen to treat patients with advanced oesophageal carcinoma

BACKGROUND: A phase II study was performed to investigate the safety and efficacy of weekly doses of combined paclitaxel and 5-fluorouracil (5-FU) with concurrent radiation therapy, followed by 2 cycles of consolidation chemotherapy to treat patients with advanced oesophageal carcinoma. METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Yi, Li, Yun-hai, Chen, Yun, Zhang, Jun-hua, Liu, Qi, Deng, Jia-ying, Ai, Ta-shan, Zhu, Han-ting, Fan, Jian-hong, Badakhshi, Harun, Zhao, Kuai-le
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341476/
https://www.ncbi.nlm.nih.gov/pubmed/28270162
http://dx.doi.org/10.1186/s13014-017-0785-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341476/
https://www.ncbi.nlm.nih.gov/pubmed/28270162
http://dx.doi.org/10.1186/s13014-017-0785-0

Ejemplares similares